ClinicalTrials.Veeva

Menu

A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face (LESS)

Merz Pharmaceuticals logo

Merz Pharmaceuticals

Status and phase

Completed
Phase 1

Conditions

Sebum Production
Enlarged Pores

Treatments

Drug: NT 201
Drug: Placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT05784363
M602011077

Details and patient eligibility

About

The purpose of this study is to investigate the efficacy and safety of NT 201 injections in the treatment of enlarged pores and excessive sebum production in the face.

Full description

Eligible subjects will be randomized to one of the two treatment groups: NT 201 group and placebo in order to receive one session of injections with either NT 201 or placebo in the upper face (forehead and cheek area) on Day 1 and followed for about 90 days after treatment.

Enrollment

31 patients

Sex

All

Ages

21 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cheek pore size assessed as "large" by the investigator
  • Oily skin on the forehead

Exclusion criteria

  • Treatment with Botulinum toxin (BoNT) of any serotype in the face within the last 12 months
  • Facial cosmetic procedure (e.g., chemical peel, photo rejuvenation, mesotherapy, photodynamic therapy, laser treatment, ultrasound treatment, tattooing of eyebrows) within the last 12 months
  • Treatment with any dermal filler in the face within the last 12 months
  • Any previous insertion of permanent material in the face, including permanent dermal fillers (e.g., silicone, polymethyl methacrylate)
  • Any medical condition that may put the subject at increased risk with exposure to botulinum toxin of any serotype

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

31 participants in 2 patient groups, including a placebo group

NT 201
Experimental group
Description:
Single NT 201 injection treatment.
Treatment:
Drug: NT 201
Placebo
Placebo Comparator group
Description:
Single placebo injection treatment.
Treatment:
Drug: Placebo

Trial contacts and locations

3

Loading...

Central trial contact

Public Disclosure Manager Merz Aesthetics

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems